Failure of terfenadine in relieving the pruritus of atopic dermatitis
- PMID: 2574594
- DOI: 10.1111/j.1365-2133.1989.tb08196.x
Failure of terfenadine in relieving the pruritus of atopic dermatitis
Abstract
We report the results of a double-blind, placebo-controlled, cross-over study of terfenadine 120 mg twice daily for pruritus in atopic dermatitis. Twenty-eight subjects with chronic atopic dermatitis received both terfenadine 120 mg b.d. and placebo each for a period of 1 week. Response was recorded by the subjects using visual analogue scales for severity of pruritus twice daily for the last 4 days of each treatment phase. There was no benefit from terfenadine.
Comment in
-
Cross-over designs for clinical trials.Br J Dermatol. 1991 Feb;124(2):208. doi: 10.1111/j.1365-2133.1991.tb00437.x. Br J Dermatol. 1991. PMID: 2004009 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical